Project Grant K43TW013092
- The Fogarty International Center (FIC) of the National Institutes of Health awarded a $100,720 Project Grant under the International Research and Research Training program (CFDA 93.989) to The Infectious Diseases Institute Limited (IDI) in Uganda. The grant, titled "HIGH-PERFORMANCE COMPUTING FOR HIV RESEARCH EXCELLENCE (HPC4HIV)", aims to strengthen IDI's capacity to support Ugandan biomedical research, particularly HIV research, by training four local staff in high-performance...
- The Fogarty International Center (FIC), part of the National Institutes of Health (NIH), awarded a $268,665 project grant to the Joint Clinical Research Centre (JCRC) in Uganda under the International Research and Research Training program (CFDA 93.989). The grant, titled "Leveraging North-South Partnerships to Advance Cell and Gene Therapy for HIV Research Training Capacity in Uganda (C and GT-Uganda)," aims to strengthen research training capacity for cell and gene therapy approaches...
- The Fogarty International Center (CFDA 93.989) awarded a $100,987 Project Grant to Mu-Jhu Care LTD in Uganda on May 19, 2025. The grant aims to strengthen the Research Compliance and Integrity (RCI) office capacity for rigorous oversight of HIV clinical trials at the Makerere University-Johns Hopkins University Research Collaboration. Key activities include providing the RCI lead staff with advanced training in research compliance and integrity management from Johns Hopkins University and the...
- The Department of Health and Human Services' Fogarty International Center has awarded a $303,316 Project Grant under the CFDA 93.989 International Research and Research Training program to Makerere University College of Health Sciences in Uganda. The grant, titled "Harnessing Health Data Science Capacity to Strengthen Evidence-Based Interventions, Policy and Response to the HIV/AIDS Epidemic in Uganda (H-DATA)", aims to train Ugandan scientists and healthcare practitioners in health...
- The Fogarty International Center (FIC), part of the U.S. Department of Health and Human Services' National Institutes of Health, has awarded a $169,015 Project Grant (CFDA 93.989) to Kenyatta National Hospital in Kenya. The goal of this 5-year grant, awarded on September 16, 2025, is to develop and evaluate a urine dipstick-guided counseling intervention to support adherence and completion of the 3-month isoniazid with rifapentine (3HP) tuberculosis preventive therapy regimen among people with...
- The federal Project Grant award of $101,290 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) aims to strengthen grants administration capacity at the Makerere University College of Health Sciences in Uganda. The key products and services to be delivered under this award include: Providing advanced training and mentorship to senior research administrators at Makerere University on best practices for pre- and post-award...
- This $302,142 Project Grant awarded by the Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to strengthen the capacity of researchers in Uganda to conduct HIV treatment and prevention clinical trials in perinatal, pediatric, adolescent, and at-risk populations, including women and their partners. The grant recipient, Mu-Jhu Care LTD, an international organization based in Kampala, Uganda, will establish a training center to offer short-term,...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), provides $897,448 to The Johns Hopkins University to conduct research on the causality of post-tuberculosis (TB) lung disease in rural Uganda. The study aims to evaluate lung function and respiratory symptoms both before and after TB diagnosis to better understand how much post-TB sequelae reflect the TB disease...
- This federal Project Grant award of $709,902 from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to establish a well-characterized cohort of individuals with post-tuberculosis lung disease (PTLD) in Uganda. The key objectives are to determine whether sex, HIV serostatus, and air pollution exposure are associated with distinct lung function and chest imaging phenotypes of PTLD. The award will support the enrollment of 650 post-TB and 165 non-TB...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $712,268 Project Grant award from the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) to establish the Uganda Lung Health Study. This 5-year longitudinal study aims to investigate the intersection of HIV, sex, and chronic obstructive pulmonary disease (COPD) risk among 800 adolescents and adults in Sub-Saharan Africa, a region expected to...
The Fogarty International Center (FIC) under the U.S. Department of Health and Human Services awarded a $124,524 Project Grant under the International Research and Research Training program (CFDA 93.989) to Makerere University Lung Institute Limited in Uganda. The grant supports research led by Dr. Alex Kayongo, MD-PhD, aimed at uncovering the relationship between the airway microbiome and immune response in people living with HIV who develop chronic obstructive pulmonary disease (COPD). Through advanced training in multi-omics analysis and close mentorship from experts in the U.S. and Uganda, Dr. Kayongo seeks to gain the skills necessary to become an independent investigator focused on this critical global health issue. The research will be conducted in Uganda, a country with a high prevalence of HIV and increasing COPD-related morbidity and mortality, in order to generate evidence-based strategies for improving lung health outcomes in this population.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $124.5k | 9/14/25 |